INTRODUCTION
============

5′-Adenosine monophosphate--activated protein kinase (AMPK) is an evolutionarily conserved serine/threonine kinase that serves as a sensor of cellular and organismal energy balance and stress ([@B9]; [@B23]). AMPK is activated by physiological (hormones) or pathophysiological (cellular stress) signals that either elevate intracellular Ca^2+^ or produce decreases in cellular ATP levels, resulting in an increase in AMP and ADP levels. AMPK is maximally activated when threonine 172 (T172) in the activation loop is phosphorylated and when AMP or ADP is bound ([@B22]). Two upstream kinases---the tumor suppressor LKB1 (liver kinase B1) and (Ca^2+^/calmodulin-dependent kinase kinase β (CaMKKβ)---phosphorylate T172 of the α subunit. It has been proposed that phosphorylation by LKB1 is AMP dependent, whereas phosphorylation by CaMKKβ is AMP independent and enhanced by elevated intracellular Ca^2+^ levels ([@B52]). On its activation, AMPK restores energy balance by activating energy-producing catabolic pathways and inhibiting energy-consuming anabolic pathways, as well as by regulating transcription to achieve both short- and long-term adaptive responses in a wide range of tissues ([@B41]; [@B36]). In the context of neuronal development, one group using a genetic loss-of-function approach showed that under normal conditions, AMPK catalytic activity is not required for neurogenesis, polarization, or survival in vivo ([@B51]). However, during neuronal polarization, metabolic stress results in the activation of AMPK, leading to the inhibition of axon formation and growth in a mechanistic target of rapamycin-- and Akt-dependent manner ([@B3]; [@B51]).

The AMPK kinase complexes (denoted by the catalytic isoforms α1 or α2) are members of a larger family of 13 AMPK-related kinases that are also activated by the upstream LKB1 kinase ([@B34]; [@B33]). Among the AMPK-related kinases, the brain-specific kinases 1 and 2 (BRSK1 and BRSK2, also known as SAD-B and SAD-A, respectively) share significant homology with AMPK α1 and α2 in their kinase domains ([@B1]). The BRSKs are highly expressed in neurons, and it has been demonstrated that activation of LKB1 and BRSK promotes the establishment of neuronal axon--dendrite polarity and synaptic development both in vivo and in vitro ([@B27]; [@B25]; [@B5]; [@B45]; [@B11]).

Although both AMPK and BRSK play important roles in developing neurons, their regulation in developing neurons is not completely understood. For example, in addition to LKB1, there is conflicting evidence that the Ca^2+^/CaMKK and cAMP/protein kinase A (PKA) pathways stimulate BRSK activity ([@B20]; [@B8]; [@B18]; [@B46]). Furthermore, although both AMPK and BRSK are involved in the regulation of cell polarity in neurons and other cell types, little information exists regarding their spatiotemporal activation patterns in polarized cell types ([@B21]).

Given the complexity of AMPK and BRSK signaling and the important roles they play in neurons as well as in a multitude of other cell types, our understanding would benefit significantly by methods that allow monitoring of kinase activity in a native context. Genetically encodable fluorescence resonance energy transfer (FRET)--based reporters are powerful tools that can be used to visualize signaling dynamics with high spatiotemporal resolution. A FRET-based AMPK activity reporter (AMPKAR; [@B47]) has been developed based on the general design of genetically encoded kinase activity reporters ([@B37]). In this reporter, a fluorescent protein FRET pair flanks a kinase activity--dependent molecular switch comprising an AMPK substrate sequence optimized using a positional scanning peptide library screen ([@B48]) and forkhead-associated domain 1 (FHA1), a protein module that binds to the phosphorylated substrate. Activation of AMPK and consequent phosphorylation of the substrate motif within the reporter drive a conformational change in the molecular switch, which alters the relative distance and orientation of the two fluorophores and resulting in an increase in FRET. In this study, we report the improvement and further characterization of this FRET-based kinase activity reporter. Using the improved reporter, we investigated AMPK and BRSK activation pathways in discrete subcellular locations in primary cultures of developing rat hippocampal neurons and discovered distinct spatiotemporal activity patterns for these two kinases.

RESULTS
=======

Improvement of a FRET-based reporter
------------------------------------

In the previously described AMPKAR ([@B47]), the FRET pair consists of an enhanced cyan fluorescent protein (ECFP) as the donor fluorophore and a yellow fluorescent protein variant, cpVenusE172, as the acceptor fluorophore ([@B24]). The substrate sequence within this reporter is MRRVATLVDL, in which the threonine is phosphorylated by AMPK ([@B47]). To facilitate the detection of subtle changes in AMPK activity, we set out to further improve the reporter. We previously showed that kinase activity reporters benefit from using brighter variants of CFP and yellow fluorescent protein (YFP; [@B2]; [@B14]). We replaced the ECFP from the reporter with a brighter cyan variant, cerulean3 ([Figure 1A](#F1){ref-type="fig"}; [@B35]). Similar to the original reporter, Cos7 cells transfected with the new reporter displayed a uniform distribution of fluorescence throughout the cell ([Figure 1B](#F1){ref-type="fig"}). When these cells were stimulated with 20 mM 2-deoxyglucose (2-DG), an inhibitor of glycolysis and activator of AMPK that exerts its effects through LKB1, we observed a robust and sustained response of 39.4 ± 2.1% ([Figure 1C](#F1){ref-type="fig"}). This response was measured as an increase in the ratio of YFP emission to CFP emission upon CFP excitation. On comparison to the original reporter, which showed a response of 18.3 ± 1.7% in Cos7 cells, the new reporter exhibited twofold-enhanced response ([Figure 1D](#F1){ref-type="fig"}). To test its response to AMPK activation mediated by CaMKKβ, we treated Cos7 cells with 1 μM ionomycin, a calcium ionophore. This reporter showed a rapid and transient response of 51.5 ± 3.1% ([Figure 1E](#F1){ref-type="fig"}), doubling the original reporter response of 24.4 ± 5.1% ([Figure 1F](#F1){ref-type="fig"}). To ensure that the observed responses were due to phosphorylation of the threonine in the substrate motif of the reporter, we mutated this threonine to an alanine and tested the mutant reporter. Cos7 cells expressing this mutant reporter did not respond to either 2-DG ([Figure 1C](#F1){ref-type="fig"}) or ionomycin ([Figure 1E](#F1){ref-type="fig"}), suggesting that the responses seen with the reporter were indeed dependent on phosphorylation of the designated threonine.

![Development of an improved AMPK activity reporter and its characterization in Cos7 cells. (A) Domain structure of the original and improved reporter, composed of a CFP variant, FHA1 phospho--amino acid--binding domain, AMPK substrate motif, and a variant of YFP. (B) YFP direct images of the original and improved reporter show uniform and similar expression patterns throughout the cell. (C) Time course of average response of the improved activity reporter (black curve; number of cells *n* = 8) and phosphorylation-deficient T/A mutant (red curve; *n* = 4) to 20 mM 2-DG stimulation. Reporter responses are normalized to the ratio before the point of drug addition. (D) Bar graph response comparison of original and improved activity reporters to 2-DG stimulation. (E) Time course of average responses of the improved reporter to 1 μM ionomycin and 10 mM Ca^2+^ stimulation (black curve; *n* = 9) and T/A mutant (red curve; *n* = 3). (F) Bar graph response comparison of original and improved activity reporters to ionomycin stimulation.](1935fig1){#F1}

Visualizing AMPK activity in developing rat hippocampal neurons
---------------------------------------------------------------

Next we set out to analyze the activity and regulation of AMPK in developing neurons. It has been shown that AMPK plays a crucial role in the regulation of axon initiation, as its activation has been shown to halt the process of axon specification and growth, leading to a loss of neuronal polarization ([@B3]; [@B51]). Although AMPK is expressed throughout the neuron, it is not known whether it is differentially active in axons versus dendrites in polarized neurons ([@B49]). In the first series of experiments, we examined primary rat undifferentiated hippocampal neurons (HNs) characterized by multiple neurites but lacking distinct axon--dendrite polarity ([Figure 2](#F2){ref-type="fig"}). When these neurons at 1 d in vitro (DIV 1) expressing the FRET-based reporter were stimulated with 2-DG to activate AMPK (Supplemental Figure S1), we observed a sustained response of 9.0 ± 1.1% in the cell body and 9.7 ± 0.5% in the neurites ([Figure 2C](#F2){ref-type="fig"}). Addition of ionomycin resulted in an emission ratio change of 29.30 ± 3.7% in the cell body and 31.0 ± 2.3% in the neurites ([Figure 2D](#F2){ref-type="fig"}). The lower response to 2-DG than with ionomycin could be due to the fact that the majority of the upstream kinase LKB1 is in the nucleus at this stage ([@B45]). These data suggest that both energetic stress (through 2-DG stimulation) and calcium influx (through ionomycin stimulation) uniformly activate AMPK in undifferentiated neurons.

![Undifferentiated rat hippocampal neurons show uniform stimulated AMPK activity. (A) Pseudocolor images of undifferentiated neurons showing the response to ionomycin followed by Ca^2+^. Scale bar, 10 μm. (B) Bar graphs representing starting ratios in the cell body and neurites (*n* = 9). (C) Representative response curves of the improved reporter to 40 mM 2-DG stimulation in the cell body (black curve) and neurites (gray curve). (D) Representative response curves of the improved reporter to 1 μM ionomycin and 10 mM Ca^2+^ in cell body (black curve) and neurites (gray curve). The data are from at least five independent hippocampal neuron culture preparations.](1935fig2){#F2}

In the next series of experiments, we investigated whether the reporter responses displayed any spatial differences in differentiated rat HNs on DIV 5 that have a discrete axon--dendrite polarity (Supplemental Figure S2) and also high expression levels of AMPK subunits ([@B40]). For the purposes of the analysis of the responses, the neurons were segmented into the cell body and dendrites, and the axons were divided into three equal regions of interest up to the point of branching into the axon terminal (Supplemental Figure S2B). On stimulation of these cells, the cell body, the dendrites, and the axonal region immediately proximal to the cell body showed transient but robust Ca^2+^-induced responses, but, intriguingly, the distal region of the axon did not respond ([Figure 3C](#F3){ref-type="fig"}). When we analyzed the starting emission ratios---the ratio of the acceptor fluorophore emission to the donor fluorophore emission in resting cells---we found that the distal region of the axon displayed high starting emission ratios, suggesting that the probe could be basally phosphorylated ([Figure 3B](#F3){ref-type="fig"}). In contrast, the starting ratios within neurites at DIV 1 were uniform and similar to that of the cell body ([Figure 2B](#F2){ref-type="fig"}). In addition, in a separate experiment, differentiated neurons expressing the T/A mutant reporter showed no Ca^2+^-mediated responses or spatial difference in starting ratios, indicating that the observed high starting ratio in the distal region of the axon was due to basal phosphorylation of the probe ([Figure 3D](#F3){ref-type="fig"}). When differentiated neurons expressing the wild-type reporter were probed for AMPK responses via 2-DG stimulation (Supplemental Figure S1), we found a similar trend of high starting ratios and no 2-DG--stimulated responses in the distal region of the axon ([Figure 3E](#F3){ref-type="fig"}). [Figure 4](#F4){ref-type="fig"} summarizes the distinct reporter responses at each subcellular location of differentiated ([Figure 4A](#F4){ref-type="fig"}) and undifferentiated neurons ([Figure 4B](#F4){ref-type="fig"}). The key spatial difference was apparent in DIV 5 HNs when the neurites/dendrites and proximal regions of the axon were compared to the distal region of the axon, where 2-DG or Ca^2+^-mediated activation did not elicit a response, but maximum basal activity was observed.

![Differentiated rat hippocampal neurons show spatial differences in stimulated AMPK activity. (A) Pseudocolor images of differentiated neurons treated with ionomycin. Scale bar, 20 μm. (B) Bar graphs depicting starting ratios in different regions of the neuron (*n* = 10). High starting ratios are observed in the distal region of the axon. Starting ratio comparisons between different regions and the cell body in differentiated neurons were performed using one-way analysis of variance (ANOVA) followed by Dunnett\'s multiple comparison test. (C) Representative response curve of the reporter to 1 μM ionomycin in cell body (black curve), neurites (gray curve), and axon (purple curves, rightmost). The data are from at least five independent hippocampal neuron culture preparations. (D) Time course response of a phosphorylation-deficient version of the improved activity reporter in differentiated neurons. No responses were observed in cell body (black curve), neuritis (gray curve), and axon purple curves) upon ionomycin stimulation. (E) Representative response curve of the reporter to 40 mM 2-DG stimulation in the cell body (black curve), neurites (gray curve), and axon (purple curves, rightmost).](1935fig3){#F3}

![Quantification of multiple independent experiments for compartmentalized responses of the reporter in developing neurons shows spatial differences in differentiated neurons. (A) Bar graph of responses in differentiated neurons (DIV 5) depicting stimulated activity in the cell body, dendrites, and axon (*n* = 3 for ionomycin and *n* = 4 for 2-DG). Owing to similar levels of reporter expression, reporter responses in dendrites were compared with the distal region of the axon by performing unpaired *t* test followed by Welch\'s correction. (B) Bar graph of responses in undifferentiated neurons (DIV 1) depicting stimulated activity in the cell body and neurites (*n* = 6 for ionomycin and *n* = 5 for 2-DG). Reporter responses were compared by unpaired *t* tests followed by Welch\'s correction. The data are from three to five independent experiments per stimulated condition.](1935fig4){#F4}

To probe further this unique response pattern, we used short hairpin RNAs (shRNAs) to knock down the AMPK α1 and α2 catalytic subunits in HNs. Although the shRNA constructs efficiently knocked down both AMPK subunits ([Figure 5A](#F5){ref-type="fig"}), the DIV 5 HNs continued to exhibit high basal activity, as visualized by the elevated starting ratios ([Figure 5B](#F5){ref-type="fig"}). However, these cells were largely unresponsive to either 1 μM ionomycin or 40 mM 2-DG (Supplemental Figure S3), indicating that stimulated responses to 2-DG or ionomycin depend on the presence of AMPK. In similar experiments, we also knocked down the AMPK α1 subunit in HNs from AMPK α2--knockout mice and monitored the reporter responses. Stimulation with either 2-DG or ionomycin did not induce an emission ratio change in any region of the neuron ([Figure 5, C and D](#F5){ref-type="fig"}). Collectively these data demonstrate that the stimulated reporter responses, that is, changes in the emission ratios, are due to stimulated increases in AMPK activity. However, the polarized activity in the basal state as indicated by the high starting emission ratios is not dependent on AMPK activity.

![Knockdown of AMPK α1 subunits in α2-knockout hippocampal neurons abolishes stimulated response. (A) Western blot showing knockdown efficiency of the AMPK α1/2 shRNA constructs in rat hippocampal neurons. (B) Bar graphs of starting ratios in different subcellular compartments of differentiated neurons (*n* = 4). Knockdown of α1/2 subunits does not abolish high starting ratios in the distal region of the axon. Starting ratio comparisons between different regions and the cell body in differentiated neurons were performed using one-way ANOVA followed by Dunnett\'s multiple comparison test. (C) Representative response curves of the improved reporter to 40 mM 2-DG stimulation in the cell body (black curve), neurites (gray curve), and axon (purple curves, rightmost) upon AMPKα1 knock down in α2 knockout hippocampal neurons. (D) Representative response curves of the improved reporter to 1 μM ionomycin and 10 mM Ca^2+^ in cell body (black curve), neurites (gray curve), and axon (purple curves, rightmost). The data are from at least five independent hippocampal neuron culture preparations.](1935fig5){#F5}

BRSK1/2 phosphorylate the FRET-based reporter
---------------------------------------------

Although this reporter was developed based on a consensus AMPK substrate sequence ([@B47]), the possibility existed that other, related kinases could phosphorylate this reporter in a cellular context. Therefore we considered that the high basal starting ratios observed in the distal region of DIV 5 neuron axon could derive from an AMPK-related kinase. Among the AMPK-related kinases, BRSK1 and BRSK2 share significant homology with AMPKα within their kinase domains and substrate recognition regions. BRSK2 has 65% homology with the α1 subunit of AMPK, and BRSK2 is 49% homologous with α2. Both BRSK1 and 2 are highly expressed in the brain and have been implicated in establishing neuronal polarity and promoting synaptogenesis ([@B27]; [@B25]; [@B5]). Although the regulation of BRSK1/2 is not fully understood, LKB1 has been established as an upstream kinase ([@B33]; [@B8]). However, whereas one report provided evidence that CaMKKα can also activate BRSK1/2 ([@B18]), another study showed that BRSK1/2 are not responsive to ionomycin stimulation and increases in cytosolic calcium ([@B46]). Initially, to determine whether the reporter is indeed a substrate of BRSK1 and BRSK2, we performed experiments in HeLa cells, which do not natively express the BRSK1/2-activating kinase LKB1. To avoid nonspecific effects of AMPK or other related kinases, we generated constitutively active and kinase-deficient mutants of BRSK1 and BRSK2 ([@B33]). We cotransfected cells with constitutively active BRSK1 (T189E), kinase- deficient BRSK1 (K63R), constitutively active BRSK2 (T175E), or kinase-deficient BRSK2 (K49R) along with the FRET reporter. Subsequently, cells were harvested and lysates probed with a phospho-AMPK substrate antibody that was raised against the consensus AMPK substrate motif also found in this reporter. Both active BRSK1 and BRSK2 produced a threefold increase in the levels of phosphorylated reporter ([Figure 6, A and B](#F6){ref-type="fig"}) compared with the kinase-deficient variants. In contrast, microtubule affinity--regulated kinase (MARK), another AMPK-related kinase ([@B15]; [@B33]; [@B29]) that has also been shown to be present in neurons and regulate axon formation ([@B6]), did not phosphorylate the reporter (Supplemental Figure S4). These results provide evidence that in addition to AMPK, this reporter can also report on BRSK1/2 but not MARK activity in cells. We therefore named it AMPK and BRSK dual-activity reporter (ABKAR).

![The activity reporter is a substrate for BRSK1 and BRSK2 and therefore named the AMPK and BRSK dual-activity reporter (ABKAR). (A) Western blot showing that ABKAR is a substrate for BRSK1/2. (B) Immunoblot analysis using a phospho-AMPKAR substrate antibody shows increased levels of phosphorylation of the reporter in the presence of constitutively active BRSK1 (T189E) and BRSK2 (T175E) compared with catalytically inactive BRSK1 (K63R) and BRSK2 (K49R). HeLa cells coexpressing BRSK1/2 along with the reporter were used for Western blotting. The data are from four independent experiments.](1935fig6){#F6}

Polarized BRSK and AMPK activities in growing axons
---------------------------------------------------

In the next series of experiments, we investigated whether it is BRSK1/2 that contribute to the unique basal response pattern of ABKAR in the distal region of axons in differentiated HNs. Genetic ablation of BRSK1/2 in an undifferentiated neuron results in a cell that fails to form distinct axons and dendrites ([@B27]). Therefore, to determine whether BRSK basally phosphorylated ABKAR in a polarized neuron, we transfected HNs with shRNAs for BRSK1 and BRSK2 along with ABKAR at DIV 3, when axon--dendrite polarity is already established. When observed on DIV 5, although the expressions of BRSK1 and BRSK2 were reduced ([Figure 7A](#F7){ref-type="fig"}), these neurons exhibited normal polarization (Supplemental Figure S5). In these cells, the spatial difference in the starting ratios was completely abolished ([Figure 7B](#F7){ref-type="fig"}), indicating that the phosphorylation level of the probe was now comparable between different compartments of differentiated neurons. These data suggest that BRSK1/2 are basally active, with highest activity observed in the distal region of the axon.

![BRSK1 and 2 knockdown in differentiated rat hippocampal neuron does not abolish the stimulated response of the reporter and reveals polarized AMPK activity. (A) Western blot showing knockdown of BRSK1 and BRSK2. (B) Bar graphs of starting ratios in different regions of differentiated neurons (*n* = 3). Knockdown of BRSK results in abolition of high starting ratios in the distal region of the axon. (C) Representative response curve of diffusible ABKAR to 40 mM 2-DG stimulation in the cell body (black curve), neurites (gray curve), and axon (purple curves, rightmost). (D) Representative response curves of diffusible ABKAR to 1 μM ionomycin in cell body (black curve), neurites (gray curve), and axon (purple curves, rightmost). The data are from at least three independent hippocampal culture preparations.](1935fig7){#F7}

In these cells with BRSK1/2 knockdown, the AMPK activities stimulated by 2-DG ([Figure 7C](#F7){ref-type="fig"}) and ionomycin ([Figure 7D](#F7){ref-type="fig"}) were clearly observed. As shown in [Figure 7](#F7){ref-type="fig"}, the distal region of the axon exhibited maximal AMPK responses to 2-DG and ionomycin stimulation. Thus, although AMPK is known to be ubiquitously present throughout neurons, these data demonstrate that in developing neurons, stimulated AMPK activity is polarized, with elevated activity in the distal region of axons.

DISCUSSION
==========

AMPK has been designated a master energy sensor and has a well-established role in the regulation of metabolism. Evidence has emerged to suggest that AMPK also has critical functions in the regulation of cell growth, autophagy, and cellular morphology ([@B9]). These effects involve signaling from the upstream kinase LKB1, a tumor suppressor and established regulator of cell polarity ([@B1]). Studies have demonstrated that the LKB1-AMPK pathway also plays a role in neuronal polarization. Although AMPK is not required for normal CNS development or neuronal polarization, it regulates axogenesis under cellular stress conditions ([@B3]; [@B51]). It was determined that stress-activated AMPK prevents the establishment of proper neuronal morphology through the phosphorylation of the kinesin light chain of the Kif5 motor protein and mislocalization of phosphatidylyinositol-4,5-bisphosphate 3-kinase from the growing axon tip. Two other AMPK-related kinases, BRSK1 and BRSK2, are also highly expressed in the mammalian brain and are crucial for neuronal development. Mammalian BRSK1 and BRSK2 are evolutionarily conserved kinases with orthologues in *Caenorhabditis elegans* and *Drosophila* ([@B12]; [@B27]; [@B45]). Several studies reported that mutant or knockout animals exhibit impaired synaptic vesicle clustering, defective synaptogenesis, and absence of discrete axon--dendrite polarity ([@B12]; [@B27]; [@B30]).

Although it is known that AMPK, BRSK, and their upstream kinases are highly expressed in neurons, controversy exists regarding how this pathway is activated in these cells. Initial in vitro studies in heterologous systems showed that LKB1 is an upstream kinase for both AMPK and BRSK ([@B33]). However, whereas one group demonstrated LKB1-mediated phosphorylation of AMPK in neuronal cells, another study showed no reduction in AMPK phosphorylation but an absence of BRSK phosphorylation in LKB1-deficient brains ([@B5]; [@B8]). In addition, numerous studies have established a role for CaMKKβ in the Ca^2+^-mediated activation of AMPK in the brain and other tissues ([@B39]). With regard to Ca^2+^-mediated BRSK activation, one study identified CaMKKα to be an upstream activator of BRSK, whereas other studies provided evidence that neither CaMKKβ nor Ca^2+^ leads to BRSK activation ([@B8]; [@B18]; [@B17]; [@B46]). Furthermore, PKA-dependent activation of BRSK2 was suggested in one study; however, this finding could not be demonstrated in neuronal cells ([@B20]; [@B8]). In this work, using a FRET-based kinase activity reporter, we examined kinase activities in either the basal or the stimulated state in undifferentiated and differentiated rodent hippocampal neurons. We demonstrated that acute stimuli, such as changes in ATP or Ca^2+^ levels, induce AMPK activation, presumably through LKB1 and CaMKKβ, respectively. In contrast, BRSK is basally active but not sensitive to changes in ATP or Ca^2+^ levels in neurons.

Substrate-specific regulatory mechanisms may account for the observed differences. AMPK is under tighter intrinsic and extrinsic regulatory control than BRSK1/2. This regulation involves an autoinhibitory sequence within the catalytic domain that binds the catalytic site in the inactive state, as well as phosphatase-mediated dephosphorylation of T172 in the activation loop, which imparts minimal activity in the basal state ([@B38]; [@B10]; [@B23]). This regulation pattern is consistent with the idea that basally active BRSK is required for neuronal development and polarization, whereas AMPK remains inactive until it is activated to regulate axogenesis under cellular stress conditions. Thus, under the stimulated conditions of energetic stress, axonal LKB1 activates AMPK and inhibits polarization and axon growth ([@B3]; [@B51]), consistent with our observations of maximal AMPK activity after 2-DG stimulation. Future studies will focus on using ABKAR in AMPK α double-knockout mice to determine precisely the onset of BRSK activity in developing neurons.

Kinase activities are often spatially compartmentalized, and this spatial activation pattern can provide hints about their regulatory roles ([@B19]; [@B31]). Available activation-specific antibodies have limited specificity in immunocytochemistry. Hence visualization of the activation patterns of AMPK and BRSK in neurons has been difficult. In this study, we used a FRET-based biosensor, ABKAR, for analyzing the dynamic and spatially compartmentalized signaling activities of AMPK and BRSK in developing neurons. The dual specificity of ABKAR, when combined with specific knockdown via shRNA, allowed the elucidation of unique activity patterns of both these kinases within one cell type. In our study, we found that the activities of both AMPK and BRSK are polarized but under different conditions. In differentiated cells, significant basal ABKAR phosphorylation that was not present in undifferentiated neurons was detected in the distal region of the axon in neurons exhibiting distinct axon--dendrite morphologies. This basal ABKAR phosphorylation was abolished by the knockdown of BRSK1/2 but not AMPK1/2. Under stimulated conditions, whereas undifferentiated neurons exhibited uniform reporter responses, differentiated neurons displayed higher responses in the distal region of the axon compared with other regions of the axon and dendrites. Knockdown experiments revealed that this polarized, stimulated activity was due to AMPK1/2 but not BRSK1/2. This ability to visualize both AMPK and BRSK activity with ABKAR in differentiated neurons presents a unique platform to further dissect the molecular mechanisms regulating two related yet nonredundant kinases at the distal region of the axon, a hub for neuronal activity. The asymmetric basal activity of BRSK in axons may contribute to effects of LKB1 during axon initiation and extension. Furthermore, studies ([@B25]; [@B30]) suggest that BRSKs play a role in nerve terminal differentiation and neurotransmitter release. Thus, polarized BRSK activity may be involved in BRSK\'s roles in the axon at multiple stages of development. Although less is known regarding the stimulated asymmetric AMPK activity, it is possible that AMPK activation in axons may modulate growth, path finding, or synaptogenesis under normal or pathological conditions.

Regarding the mechanisms underlying polarized activity patterns of BRSK and AMPK, it has been shown that CaMKK, LKB1, AMPK, and BRSK are not spatially restricted and are expressed in both the somatodendritic and axonal regions in neurons ([@B49]; [@B42]; [@B27]; [@B5]; [@B45]; Supplemental Figure S6). In contrast, phosphorylated LKB1 (at serine 431) was localized to growing axons. Although it is controversial whether PKA or other kinase-mediated phosphorylation at serine 431 regulates LKB1 activity ([@B43]; [@B16]), it is evident that pSer 431 promotes accumulation of the LKB1/STRAD/MO25 complex in growing axons, and mutation of serine 431 to alanine abolishes axon formation ([@B5]). Thus, polarized distribution of phosphorylated LKB1 may contribute to the polarized BRSK1/2 activity observed here. However, the previous model proposes uniform accumulation of active LKB1 throughout the length of the growing axon ([@B45]). Yet our studies indicate that in a differentiated neuron, there is a gradient of basal BRSK activity or stimulated AMPK activity, the two major downstream substrates of LKB1. Future studies will examine directly LKB1 activity under these conditions to further our understanding of the establishment of these gradients of activity. Together the findings in this study lead to a better understanding of the spatiotemporal activation patterns of the two related kinases that play pivotal roles in neuronal polarity and energy regulation. In polarized neurons, BRSK is basally active, with higher activity in the axon tip. In contrast, energetic stress or Ca^2+^ influx results in AMPK activation throughout the neuron, with maximal activity in the distal region of the axon. Thus two homologous kinase family members, AMPK and BRSK1/2, are distinctly regulated in a coordinated manner.

MATERIALS AND METHODS
=====================

All animal experiments in this study were conducted in accordance with the National Institutes of Health Guide for the care and use of laboratory animals, and all protocols were approved by the Johns Hopkins University Institutional Animal Care and Use Committee. All cell culture materials were from Invitrogen (Carlsbad, CA), and other reagents were from either Invitrogen or Sigma-Aldrich (St. Louis, MO) unless otherwise stated.

ABKAR gene construction
-----------------------

Cerulean3 was PCR amplified using primers containing *Bam*HI and *Sph*I cut sites. ABKAR was generated by ligating the PCR product into the *Bam*HI and *Sph*I sites of the bacterial pRSETB (Invitrogen) AMPKAR vector and subcloning into the pcDNA3 mammalian expression vector (Invitrogen; [@B47]).

Kinase gene construction
------------------------

Flag-tagged mouse BRSK1 (NM_001003920) and BRSK2 (NM_001009929) were generated by PCR cloning. Total RNA was isolated from the BALB/c mouse cortex using the TRIzol reagent (Invitrogen). Primers containing 5′-*Bam*HI and 3′-*Eco*RI restriction sites were used to amplify full-length BRSK1 and BRSK2 using the Superscript One-Step RT-PCR kit (Invitrogen). Full-length BRSK1 and BRSK2 were ligated into the *Bam*HI and *Eco*RI sites of the pCMVTag4A vector (Agilent, Santa Clara, CA), which contains an N-terminal Flag tag. Constitutively active BRSK1-T189E (threonine 189 → glutamate), kinase-deficient BRSK1-K63R (lysine 63 → arginine), constitutively active BRSK2-T175E (threonine 175 → glutamate), and kinase-deficient BRSK2-K49R (lysine 49 → arginine; [@B33]) were generated from wild-type BRSK1 and BRSK2 using the QuikChange II Site-Directed Mutagenesis Kit (Agilent) according to the manufacturer\'s instructions. The clone for MARK4 (NM_031417) was obtained from the Invitrogen Gateway Ultimate ORF set and subcloned into the 5′-*Not*1 and 3′-*Eco*RI sites of pCMVTag4A. Constitutively active MARK4-T214E (threonine 214 → glutamate) and kinase-deficient MARK4-K88R (lysine 88 → arginine) were generated using the QuikChange kit. Constitutively active truncated AMPK1-132 and kinase-deficient AMPK K63R (lysine 63 → arginine) in the pEBG vector were obtained ([@B13]) and subcloned into the pCMVTag4A vector.

Cell culture
------------

Cos7 cells were maintained in high-glucose DMEM containing 10% fetal bovine serum (FBS), 1% penicillin-streptomycin (pen-strep), and 1 mM sodium pyruvate at 37°C and 5% CO~2~. For imaging, cells were plated onto custom-made, sterilized, glass-bottom 35-mm dishes and transfected with reporter plasmid DNA using the Lipofectamine 2000 reagent (Invitrogen) at a confluency of 50--60%. The cells were allowed to grow for 18--24 h before imaging. HeLa or HEK293T cells were maintained in low-glucose (HeLa) or high-glucose (HEK293T) DMEM containing 10% FBS, 1% pen-strep, and 1 mM sodium pyruvate at 37°C and 5% CO~2~. Cells were plated in Nunclon six-well dishes and transfected at 40x50% confluency with ABKAR and either BRSK1-T189E, BRSK1-K63R, BRSK2-T175E, BRSK2-K49R, MARK4-T214E, MARK4-K188R, AMPK1-312, or AMPK K63R vectors. The cells were harvested after 60--66 h for Western blotting analysis.

Rat primary hippocampal neuronal culture
----------------------------------------

Hippocampi were dissected from E17 Sprague--Dawley rat pups (Harlan, Indianapolis, IN) in ice-cold 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)--buffered Hank\'s balanced salt solution (HBSS; containing 20 mM HEPES, 5 mM [d]{.smallcaps}-glucose, 0.23 mM sodium pyruvate, and 0.5% pen-strep, at pH 7.4) and were dissociated using the Papain Dissociation System (Worthington, Lakewood, NJ) according the manufacturer\'s instructions. Dissociated HNs were resuspended in Neurobasal-A medium (05-0128DJ; Invitrogen) supplemented with 2% B27 supplement, 0.5% pen-strep, 2 mM glutaMAX, 3 mM [d]{.smallcaps}-glucose, and 0.23 mM sodium pyruvate. Cells were plated at a density of 4.2 × 10^4^ cells/cm^2^ on poly-[d]{.smallcaps}-lysine (PDL)--coated Nunclon six-well plates for Western blot analysis. One-half of the medium was replaced at DIV 3 with 2 μM cytosine arabinoside, and cells were given a 25--50% medium change every 3--4 d to restore glucose levels to 3 mM as previously described ([@B28]). Cells were cultured in an atmosphere-controlled, humidified incubator at 5% CO~2~ and 5% O~2~. AMPK α1 and α2--deficient mice were generated as previously described ([@B26]; [@B50]). Wild-type littermates served as controls in all experiments. Genotyping was performed as previously described. Mouse HNs were isolated as described. For imaging experiments, isolated mouse or rat HNs (2.0 × 10^6^/transfection) were electroporated with 5 μg of cDNA using the Amaxa Nucleofector device (Lonza, Walkersville, MD) according to the manufacturer\'s instructions and plated onto 35-mm glass-bottom imaging dishes. Cells were imaged after at least 18 h posttransfection.

Live-cell imaging
-----------------

Cells were washed twice with and maintained in low-glucose HBSS buffer. After identification of transfected cells, the cells were treated with 2-DG, ionomycin, calyculin A, or CaCl~2~ as indicated. Dual emission ratio imaging was performed on a Zeiss Axiovert 200M microscope with a MicroMAX BFT512 cooled charge-coupled device camera (Roper Scientific, Trenton, NJ) controlled by METAFLUOR 6.2 software (Universal Imaging, Downingtown, PA). Emission ratios were obtained using a 420DF20 excitation filter, a 450DRLP dichroic mirror, and two emission filters (475DF40 for ECFP and Cerulean and 535DF25 for cpVenus) alternated by a Lambda 10-2 filter changer (Sutter Instruments, Novato, CA). Images were taken every 15--30 s with an exposure time of 100--500 ms. Fluorescence images were background corrected by subtracting autofluorescence intensities of untransfected cells (or background with no cells) from the emission intensities of fluorescent cells expressing the reporter.

shRNA-mediated gene knockdown
-----------------------------

Individual clones for lentiviral shRNA constructs from the TRC RNAi Library (Broad Institute, Boston, MA) were purchased from Sigma-Aldrich. For knockdown of AMPK α1, clones TRCN00000360842 and TRCN00000360770 were used. For knockdown of AMPK α2, clones TRCN00000360775 and TRCN00000360848 were used. BRSK1 knockdown was achieved using clones TRCN00000368711 and TRCN00000360985. BRSK2 knockdown was achieved using clones TRCN0000363494 and TRCN0000363520. The pLKO.1 scrambled shRNA vector (plasmid 1864; Addgene, Cambridge, MA) was used as a control, as previously described ([@B44]). shRNAs (2.5 μg/clone) were transfected as lentiviral cDNA vectors as described.

Western blot analysis
---------------------

Cells were washed once with ice-cold Dulbecco\'s phosphate-buffered saline and lysed directly in 1× protein sample buffer (62.5 mM Tris-Cl, pH 6.8, 10% glycerol, 2% SDS, 1% β-mercaptoethanol, and trace amounts of bromophenol blue), boiled, and stored at −80°C. Proteins were separated by SDS--PAGE on a 4--15% gradient Tris-HCl polyacrylamide gel (Bio-Rad, Hercules, CA) and transferred to a polyvinylidene difluoride membrane (Bio-Rad). Blots were probed with the following primary antibodies overnight in Tris-buffered saline solution, pH 7.5, containing 0.1% Tween-20, 5% protease-free bovine serum albumin (BSA), and 50 mM NaF (TBST): pAMPK, pACC, tAMPK, tACC, pAMPK substrate, AMPK α1, AMPK α2, BRSK1, BRSK2 (1:1000; Cell Signaling; Danvers MA), and actin (1:500; Santa Cruz Biotechnology, Santa Cruz, CA). Blots were incubated for 2 h with the following secondary antibodies in 5% nonfat dry milk in TBST: anti-goat and anti-rabbit horseradish peroxidase (1:5000; EMD Millipore, Billerica, MA). The enhanced chemiluminescence signal was detected with the FluorChem Q imaging system (Protein Simple, Santa Clara, CA).

Immunocytochemistry
-------------------

Neurons were cultured on PDL-coated glass-bottom dishes or coverslips for 3 DIV before transfection with ABKAR and BRSK shRNAs or 5 DIV for untransfected cells. Cells were fixed with 4% paraformaldehyde (PFA; Electron Microscopy Sciences, Hatfield, PA) for 20 min at room temperature. Free PFA was quenched with 100 mM glycine in HBSS. Cells were then permeabilized and preincubated in blocking buffer (5% goat serum, 0.2% BSA, 0.1% Triton X-100, and 0.01% NaN~3~ in HBSS) for 30 min. The cells were incubated at 4°C overnight with the following primary antibodies in blocking buffer: mouse MAP2 MAB3148 (1:1000; EMD Millipore, Darmstadt, Germany), mouse Tau1 ab64193 (1:100; Abcam, Cambridge, United Kingdom), mouse NST ab14545 (1:1000; Abcam), rabbit CaMKKβ (1:500, Novus Biologicals, Littleton, CO), or mouse LKB1 (1:100, EMD Millipore). On the following day, the cells were washed three times in HBSS and incubated with goat anti-mouse Alexa Fluor 568 or goat anti-rabbit Alexa Fluor 488 secondary antibodies (1:500; Life Technologies, Carlsbad, CA) for 2 h at room temperature in the dark. Cells were then washed with HBSS three times and visualized by fluorescence microscopy. For ABKAR detection in fixed cells, the intrinsic fluorescence of the reporter was imaged using a 488/535 excitation/emission filter set. All imaging was done on the Axiovert 200M inverted epifluorescence microscope (Zeiss, Oberkochen, Germany). All image processing was done using ImageJ software (National Institutes of Health, Bethesda, MD).
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2-DG

:   2-deoxyglucose

ABKAR

:   AMPK BRSK dual-activity reporter

AMPK

:   5′-adenosine monophosphate--activated protein kinase

BRSK

:   brain-specific protein kinase

CaMKKβ

:   Ca^2+^/calmodulin-dependent protein kinase β

LKB1

:   liver kinase B1.
